Pharbinex
- Product NDC
- 73057-379
- 11-digit product format
- 730570379
- Labeler code
- 73057
- Product ID
- 73057-379_2c27dcbe-d14a-a6dd-e063-6294a90a9395
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin 400mg
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Ulai Health LLC
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2019-06-26
- Substance
- GUAIFENESIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pharbinex
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GUAIFENESIN | 400 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 495W7451VQ |
| Rxcui | 359601 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 73057-379-04 | Pharbinex | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 73057-379 | PHARBINEX (GUAIFENESIN 400MG) TABLET [ULAI HEALTH LLC] | 5 | Current NDC, Legacy NDC, 1 package rows | 20250122_4eafa81a-aeee-4c97-85d6-594902b10919.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 73057-379-04 | 73057037904 | 30 TABLET in 1 BOTTLE, PLASTIC (73057-379-04) | 30 tablet | 2019-06-26 | 0000-00-00 | No | No | Current |